Preferential contribution of B7-H1 to programmed death-1-mediated regulation of hapten-specific allergic inflammatory responses.
about
Triggering receptor expressed on myeloid cell-like transcript 2 (TLT-2) is a counter-receptor for B7-H3 and enhances T cell responsesBlockade of endogenous B7-H1 suppresses antibacterial protection after primary Listeria monocytogenes infectionEmerging mechanisms of immune regulation: the extended B7 family and regulatory T cellsProgrammed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2.Alloantigen expression on non-hematopoietic cells reduces graft-versus-leukemia effects in mice.CD4 T-cell help programs a change in CD8 T-cell function enabling effective long-term control of murine gammaherpesvirus 68: role of PD-1-PD-L1 interactions.Preventive and therapeutic potential of placental extract in contact hypersensitivityProgram death-1 signaling and regulatory T cells collaborate to resist the function of adoptively transferred cytotoxic T lymphocytes in advanced acute myeloid leukemia.Dendritic cell programming by cytomegalovirus stunts naive T cell responses via the PD-L1/PD-1 pathway.Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses.PDL1 is required for peripheral transplantation tolerance and protection from chronic allograft rejection.B7-1 mediated costimulation regulates pancreatic autoimmunity.The novel costimulatory programmed death ligand 1/B7.1 pathway is functional in inhibiting alloimmune responses in vivo.Involvement of programmed death-ligand 2 (PD-L2) in the development of experimental allergic conjunctivitis in miceCutting Edge: PD-1 Regulates Imiquimod-Induced Psoriasiform Dermatitis through Inhibition of IL-17A Expression by Innate γδ-Low T Cells.DC-HIL is a negative regulator of T lymphocyte activation.B7-H1-targeted immunotherapy for head and neck cancer.Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenaseInsulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway.Co-stimulatory molecules as potential targets for therapeutic intervention in allergic airway disease.Intrarenal antigens activate CD4+ cells via co-stimulatory signals from dendritic cellsProgrammed death 1 ligand signaling regulates the generation of adaptive Foxp3+CD4+ regulatory T cellsB7-H4-deficient mice display augmented neutrophil-mediated innate immunity.Polyethylenimine-based siRNA nanocomplexes reprogram tumor-associated dendritic cells via TLR5 to elicit therapeutic antitumor immunityThe role of costimulatory molecules in allergic disease and asthma.Effector and regulatory mechanisms in allergic contact dermatitis.Programmed Death Ligand 1 Promotes Early-Life Chlamydia Respiratory Infection-Induced Severe Allergic Airway Disease.Role of Th17 cells in skin inflammation of allergic contact dermatitis.Batf3-dependent dendritic cells in the renal lymph node induce tolerance against circulating antigens.Expression of PD-1/LAG-3 and cytokine production by CD4(+) T cells during infection with Plasmodium parasites.Differential control of CD4(+) T-cell subsets by the PD-1/PD-L1 axis in a mouse model of allergic asthma.Human Langerhans cells control Th cells via programmed death-ligand 1 in response to bacterial stimuli and nickel-induced contact allergy.The PTEN pathway in Tregs is a critical driver of the suppressive tumor microenvironment.PD-L2 modulates asthma severity by directly decreasing dendritic cell IL-12 production.PD-L1 blockade overrides Salmonella typhimurium-mediated diabetes prevention in NOD mice: no role for Tregs.Pig to rat cell transplantation: reduced cellular and antibody responses to xenografts overexpressing PD-L1.B7-H1 (CD274) inhibits the development of herpetic stromal keratitis (HSK).Programmed death 1 and its ligands do not limit experimental foreign antigen-induced immune complex glomerulonephritis.Intrahepatic expression of the co-stimulatory molecules programmed death-1, and its ligands in autoimmune liver disease.Egr2-independent, Klf1-mediated induction of PD-L1 in CD4+ T cells.
P2860
Q24316331-72451FC8-601F-46FA-BC7C-6E5CD278E7B4Q24652520-52518FBE-4CC5-4A69-920F-4EB4A2233C01Q24796946-DD840A87-7D3D-4F0B-A02E-F046B7CEAD3CQ30515733-9F3AC91E-CB01-4A09-9FDD-4E3D6D2A1F61Q33967995-97E6C3E0-043E-4445-A7A1-9F436B682AF5Q34046167-A72CE6FB-4DF2-4DEE-83C1-1A1AC850C594Q34172800-FCA3177B-BC15-429F-AF2F-B9F4FEAF8529Q34193534-CC045C17-AA5B-4BA6-AD41-D7B51C496BE7Q34589567-0941EB88-EB79-41CE-A902-011CB52DE3ABQ34650346-E1AA9DC5-BC91-4A67-8253-BD8E12BB090CQ34697293-A5E99527-D4EF-4054-91AB-0F1294093991Q34763699-92469360-D1BA-493C-8329-DC858A308D75Q35118927-B6ACF3E9-ADC8-445A-AE82-DCAD66E937F0Q35762001-E8259DC0-2EBE-4EE0-A6DA-35DF21D1CEB0Q35815759-E69EE1AD-58FC-448B-863D-34D254008967Q35828672-9EBF4008-E937-4193-B26B-AB0927342FDAQ35907010-4BD3A5AD-F63C-419F-9E99-DC6D56B5A16AQ35925641-B7F16EF5-9DD9-49F3-866D-AA902BB80E85Q36228158-F3D8065C-F367-40DD-AFEB-73135690F7DDQ36360561-16E4AE0D-4311-42DC-92F3-DCF3362A0C3EQ36667235-90C72AB7-A98C-4507-86DC-ED4D4F4966F8Q36742588-340C6BC4-B28D-47A2-9000-D3A5A3E28BC4Q37109394-8F4BAFD4-CF44-42E9-9620-F7C620117C5CQ37286656-815FEF22-17D1-47BC-B8B1-14D299E09123Q37604805-251BE191-AF65-4897-9D56-2C5B46A7AB85Q37617470-82B30992-9901-41D5-AD3D-669781F429B7Q37839059-8211124B-CC7C-4A17-9472-8610850E5074Q38136193-0E18C476-3F95-4385-895F-42E7DA30601AQ39333589-45312A4F-5DD6-4C7F-BE96-AA86AE664180Q40860198-628A1854-63D1-4E57-A6C6-9901183F03C0Q40926046-F4C8FED3-C30C-403A-8742-EF752F1E886DQ41813956-B885C70D-D071-4958-8D5D-E3ADC7328B48Q41866457-23317827-C36C-4403-879C-E95781BA7AE0Q43220263-57FF7C8E-AE41-4E36-95C4-0AD53CEC767DQ43470282-59665AED-A478-4A88-9BE8-C644C491ABFFQ43556717-B145E666-EFB1-4E09-93F6-2336D67A2366Q45105481-56A70735-B6A2-4F17-A1E4-441EDE146020Q48081296-1B37FEEA-F30F-4E30-832C-369295B542A1Q53542976-7CBED4DD-7146-4EF8-A863-96E3648A2F19Q54959007-BF6A3603-5C37-4572-ACA3-3870D35C72A8
P2860
Preferential contribution of B7-H1 to programmed death-1-mediated regulation of hapten-specific allergic inflammatory responses.
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Preferential contribution of B ...... lergic inflammatory responses.
@ast
Preferential contribution of B ...... lergic inflammatory responses.
@en
Preferential contribution of B ...... lergic inflammatory responses.
@nl
type
label
Preferential contribution of B ...... lergic inflammatory responses.
@ast
Preferential contribution of B ...... lergic inflammatory responses.
@en
Preferential contribution of B ...... lergic inflammatory responses.
@nl
prefLabel
Preferential contribution of B ...... lergic inflammatory responses.
@ast
Preferential contribution of B ...... lergic inflammatory responses.
@en
Preferential contribution of B ...... lergic inflammatory responses.
@nl
P2093
P4510
P356
P1476
Preferential contribution of B ...... lergic inflammatory responses.
@en
P2093
Fumihiko Tsushima
Hideyuki Iwai
Hisaya Akiba
Ko Okumura
Masaaki Abe
Miyuki Azuma
Noriko Otsuki
Sachiko Hirose
Tomohide Yamazaki
P304
P356
10.1002/EJI.200324084
P407
P50
P577
2003-10-01T00:00:00Z